Literature DB >> 16965494

The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study.

Olafur M Björnsson1, Per Syrdalen, Alan C Bird, Tundo Peto, Bettina Kinge.   

Abstract

PURPOSE: To examine the prevalence of early and late age-related maculopathy (ARM) in citizens aged 51 years and older in the city of Oslo and its surroundings.
METHODS: We selected a random sample of 800 subjects, using a cross-sectional study design. A total of 459 of the 770 eligible subjects agreed to participate, giving an attendance rate of 59.6%. Stereoscopic colour digital photographs were obtained and graded at a certified reading centre using the International Classification Grading System for ARM.
RESULTS: Early ARM in either eye was found in 43.1% (95% CI 38.5-47.7) of subjects aged 51 years and older. This was due to a much higher prevalence of pigmentary changes, predominantly hyperpigmentation in all age groups, than previously reported; 37.5% of people aged 51-60 years of age had pigmentary changes > or = 63 microm, increasing to 66.0% in the oldest age group. In people aged 71 years and older, geographic atrophy (GA) was found in either eye in 3.6% (95% CI 0.4-6.8) and exudative macular degeneration (AMD) was found in either eye in 2.9% (95% CI 0.0-5.7) of subjects.
CONCLUSION: To our knowledge, this is the first published study to rely solely on digital photography for grading purposes in a population-based study. Early ARM was found to have a higher prevalence than previously reported in other populations. Exudative AMD and GA had similar prevalences to those described in the literature, although the prevalence of GA tended to be higher than previously reported in some surveys.

Entities:  

Mesh:

Year:  2006        PMID: 16965494     DOI: 10.1111/j.1600-0420.2006.00696.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  11 in total

Review 1.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

2.  Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study.

Authors:  Wanjiku Mathenge; Andrew Bastawrous; Tunde Peto; Irene Leung; Allen Foster; Hannah Kuper
Journal:  PLoS Med       Date:  2013-02-19       Impact factor: 11.069

3.  Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.

Authors:  Alexandra Wexler; Trond Sand; Tor B Elsås
Journal:  BMC Ophthalmol       Date:  2010-05-13       Impact factor: 2.209

4.  Combination therapy for choroidal neovascularisation.

Authors:  Albert J Augustin; Indre Offermann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study.

Authors:  E J-C Huang; S-H Wu; C-H Lai; C-N Kuo; P-L Wu; C-L Chen; C-Y Chen; Y-C King; P-C Wu
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

6.  Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.

Authors:  Johanna M Colijn; Gabriëlle H S Buitendijk; Elena Prokofyeva; Dalila Alves; Maria L Cachulo; Anthony P Khawaja; Audrey Cougnard-Gregoire; Bénédicte M J Merle; Christina Korb; Maja G Erke; Alain Bron; Eleftherios Anastasopoulos; Magda A Meester-Smoor; Tatiana Segato; Stefano Piermarocchi; Paulus T V M de Jong; Johannes R Vingerling; Fotis Topouzis; Catherine Creuzot-Garcher; Geir Bertelsen; Norbert Pfeiffer; Astrid E Fletcher; Paul J Foster; Rufino Silva; Jean-François Korobelnik; Cécile Delcourt; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2017-07-14       Impact factor: 12.079

7.  Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.

Authors:  William Seiple; Danna Jennings; Richard B Rosen; Leona Borchert; Lee Canale; Nora Fagan; Mark Forrest Gordon
Journal:  Parkinsons Dis       Date:  2016-12-18

8.  The Impact of Age-Related Macular Degeneration on Quality of Life and Its Association With Demographic Data: Results From the NEI VFQ-25 Questionnaire in a Norwegian Population.

Authors:  Ana Carla Schippert; Elma Jelin; Morten C Moe; Turid Heiberg; Ellen Karine Grov
Journal:  Gerontol Geriatr Med       Date:  2018-09-20

Review 9.  The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health.

Authors:  Declan Timothy Waugh
Journal:  Int J Environ Res Public Health       Date:  2019-03-08       Impact factor: 3.390

10.  Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study.

Authors:  Raba Thapa; Sanyam Bajimaya; Govinda Paudyal; Shankar Khanal; Stevie Tan; Suman S Thapa; Ger van Rens
Journal:  Clin Ophthalmol       Date:  2017-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.